Search Results - "Galley, Samantha"

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System by Frei, Christopher R., Le, Hannah, McHugh, Daniel, Ryan, Kellie, Jones, Xavier, Galley, Samantha, Franklin, Kathleen, Baus, Courtney J., Tavera, Juan, Janania-Martinez, Michelle, Gregorio, David, Ananth, Snegha, Uribe, Ricardo, Surapaneni, Prathibha, Espinoza-Gutarra, Manuel, Song, Michael M., Teng, Chengwen, Obodozie-Ofoegbu, Obiageri O., Nooruddin, Zohra

“…The US veteran population has a high proportion of chronic lymphocytic leukemia (CLL) risk factors. Using the Veterans Health Administration (VHA) population,…”
Get full text

Adverse event clusters present at dose-reduction in CLL patients on ibrutinib in the U.S. Veterans Health Administration by Frei, Christopher R, Ryan, Kellie, Le, Hannah, McHugh, Daniel, Obodozie-Ofoegbu, Obiageri O, Teng, Chengwen, Jones, Xavier, Galley, Samantha, Franklin, Kathleen, Tavera, Juan, Janania Martinez, Michelle, Gregorio, David, Ananth, Snegha, Uribe, Ricardo, Surapaneni, Prathibha, Espinoza-Gutarra, Manuel Ricardo, Song, Michael, Nooruddin, Zohra

“…Abstract only 252 Background: Previously, we reported that adverse events (AEs) were the top reason for dose reductions in VHA patients on novel agents. Some…”
Get full text

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting by Frei, Christopher R, Le, Hannah, McHugh, Daniel, Elesinmogun, Cynthia, Galley, Samantha, Franklin, Kathleen, Tavera, Juan, Janania Martinez, Michelle, Gregorio, David J, Ananth, Snegha, Uribe, Ricardo, Surapaneni, Prathibha, Espinoza-Gutarra, Manuel Ricardo, Song, Michael, Jones, Xavier, Teng, Chengwen, Obodozie-Ofoegbu, Obiageri O, Nooruddin, Zohra

“…Introduction: CLL is the most common chronic leukemia in the US, with nearly 20,000 new cases expected annually. Novel agents, such as ibrutinib, idelalisib,…”
Get full text